Tradestie Institutional Equity Comparison Engine

ADPT vs PVLA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADPT Overall Edge

ADPT Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adaptive Biotechnologies Corporation Common Stock (ADPT) driven by superior Momentum & Technical, Options & Structure while PVLA counters with relative strength in Growth & Margin. Fundamentally, ADPT trades at N/M Forward P/E with -16.2% operating margin (-10.7% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ADPT sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ADPT N/M vs PVLA N/M Fwd P/E
Growth & Margin Winner PVLA
Op Margin -16.2% vs 0.0% ยท YoY -10.7% vs +0.0%
Momentum & Technical Winner ADPT
1Y +98.0% vs +80.2% ยท 52W Pos 79% vs 68%
Options & Structure Winner ADPT
CONSOLIDATION (32nd %ile IV) vs CONSOLIDATION (2nd %ile IV)
ADPT NASDAQ
Adaptive Biotechnologies Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$28.00
-3.58% 1D
Market Cap $4.7B
1M Return +16.57%
1Y Return +98.02%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 43.0 Flow 69.0 Mom 54.0
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.2 / 100 HOLD
Tech 35.0 Fund 53.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADPT +98.02% PVLA +80.16% Spread: +17.86 pp (ADPT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ADPT Revenue PVLA Revenue ADPT Op. Margin PVLA Op. Margin Margin Edge
FY2018 $60M $30M -89.4% -113.1% ADPT
FY2019 $90M $40M -92.1% -62.2% PVLA
FY2020 $100M $30M -155.3% -115.7% PVLA
FY2021 $150M $30M -135.4% -165.0% ADPT
FY2022 $190M $30M -108.0% -167.8% ADPT
FY2023 $170M $40M -133.3% -27.7% PVLA
FY2024 $180M N/A -90.8% N/A ADPT
FY2025 $280M N/A -20.6% N/A ADPT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADPT (4) vs PVLA (4)
Institutional Metric ADPT PVLA Criterion Row Winner
Market Capitalization Scale $4.7B $2.2B Larger Scale ADPT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -10.7% +0.0% Higher Growth PVLA
Operating Margin (TTM) Profitability -16.2% 0.0% Higher Margin PVLA
Net Profit Margin Profitability -23.7% 0.0% Higher Margin PVLA
Return on Equity (ROE) Capital Efficiency -36.4% -63.4% Higher ROE ADPT
52-Week Range Position Momentum 79% ($12โ€“$32) 68% ($72โ€“$180) Stronger Trend ADPT
Beta / 30D Volatility Risk Regime 1.75ฮฒ ยท 60% Vol 1.66ฮฒ ยท 75% Vol Lower Realized Risk ADPT
Unified Institutional Score Composite Signal 43.8 / 100 (HOLD) 48.2 / 100 (HOLD) Higher Composite PVLA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADPT vs PVLA Buy Guide
ADPT CONSOLIDATION
69d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ADPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADPT nor PVLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.